Deal-hungry Verily secures $1B in fresh funding, months after pressing pause on smart lens project
Roughly two years after procuring its first outside investment, Verily — the prolific deal-making life sciences unit of Alphabet — has secured $1 billion in fresh funds …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
